↓ Skip to main content

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse

Overview of attention for article published in Psychopharmacology, June 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user
patent
3 patents

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
108 Mendeley
Title
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse
Published in
Psychopharmacology, June 2010
DOI 10.1007/s00213-010-1888-6
Pubmed ID
Authors

Margaret Haney, Carl L. Hart, Suzanne K. Vosburg, Sandra D. Comer, Stephanie Collins Reed, Ziva D. Cooper, Richard W. Foltin

Abstract

Only a small percentage of individuals seeking treatment for their marijuana use achieves sustained abstinence, suggesting more treatment options are needed.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 108 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 108 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 23 21%
Other 12 11%
Student > Ph. D. Student 12 11%
Student > Master 12 11%
Student > Bachelor 11 10%
Other 18 17%
Unknown 20 19%
Readers by discipline Count As %
Medicine and Dentistry 30 28%
Psychology 20 19%
Neuroscience 9 8%
Biochemistry, Genetics and Molecular Biology 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Other 12 11%
Unknown 27 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#1,892,477
of 23,283,373 outputs
Outputs from Psychopharmacology
#455
of 5,389 outputs
Outputs of similar age
#6,637
of 97,303 outputs
Outputs of similar age from Psychopharmacology
#5
of 35 outputs
Altmetric has tracked 23,283,373 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,389 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,303 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.